Neuroimaging for differentiating vascular from alzheimer's dementias

Cerebrovascular and Brain Metabolism Reviews

Volumn 8, Issue 1, 1996, Pages 1-10

  Meyer, John Stirling ^a   Shirai, Toshitaka ^a   Akiyama, Hisanao ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer dementia; Diagnosis; Neuroimaging; Vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; HUMAN; IMAGE PROCESSING; MIDDLE AGED; MULTIINFARCT DEMENTIA; PATHOLOGY; REVIEW;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; DEMENTIA, VASCULAR; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED;

EID: 0030111331     PISSN: 10408827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Alavi A, Naubers A, Sonder E, Reivich M. Comparison of quantitative magnetic resonance imaging and positron emission tomography between patients with dementia of the Alzheimer's type and multi-infarct dementia. J Stroke Cerebrovasc Dis 1992 ;2:218-21.
2. American Psychiatric Association. Diagnostic and statistical manual of related disorders. 3rd ed. rev. Washington, D.C.: American Psychiatric Press, 1987.
3. Blacker D, Albert MS, Bassett SS, Go RCP, Harrell LE, Folstein MF. Reliability and validity of NINCDSADRDA criteria for Alzheimer's disease. Arch Neural 1994;51:1198-204.
4. Chui HC, Victoroff JI, Margolin D, Jagust W, Sbankle R, Katzman R. Criteria for the diagnosis of ischémie vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-80.
5. Cummings JL. Dementia: the failing brain. Lancet 1994;345:1481-41.
6. Davis KL, Thai LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, Morris JC, Kawas CH. Knopman DS, Earl NL, Kumar V, Doody RS. A doubleblind, placebo-controlled multi-center study of tacrine for Alzheimer's disease. N Eng/ J Med 1992;327:1253-9.
7. Davis PC, Gray L, Albert M, Wilkinson W, Hughes J, Heyman A, Gado M, Kumar AJ, Destian S, Lee C, Duvall E, Kido D, Nelson MJ, Bello J, Weathers S, Jolesz F, Kekimis R, Brooks M. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) part III. Reliability of a standardized MRI evaluation of Alzheimer's disease. Neurology 1992;42:1676-80.
8. de Leon MJ, Ferris SH, George AE, Reisberg B, Christman DR, Kricheff II, Wolf AP. Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease../ Cereb Blood Flow Metah 1983;3:391 -A.
9. de Leon MJ, Colomb J, George AE, Cenvit A, Tarsliish CY, McRae T, De Saub S, Smith G, Ferris SH, Noz M, Rusinek H. The radiologie predictor of Alzheimer disease: the atrophie hippocampal formation. AJNR 1993;14:897~906.
10. del Ser T, Bermejo F, Portera A, Arredondo JM. Bouras C, Constantinidis J. Vascular dementia: a clinicopathological study. J Neural Sei 1990;96:l-7.
11. Deweer B, Lehericy S, Patton B, Baulac M, Chiras J, Marshall C, Agid Y, Dubois B. Memory disorders in probable Alzheimer disease: the role of hippocampal atrophy as shown with MRI. J Neural Neurosurg Psvchiatry 1993;58:590-7.
12. Drachman DA. New criteria for the diagnosis of vascular dementia: do we know enough yet? Neuralogv 1993:43:243-5.
13. Edland SD, LmT, Heyman A. The CERAD experience part VIII: neuroimaging-neuropathology correlation of temporal lobe changes in Alzheimer's disease. Neurology 1995;45:178-9.
14. Erkinjuntti T, Haltia M, Palo J, Salkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical post-mortem neuropathological study. J Neural Neurosurg Psvchiatry 1988;51:1037-44.
15. Fisher P, Jellinger K, Gaherer G, Danielczyk W. Prospective neuropathological validation of Hachinski's ischémie score in dementias. J Neural Neurosurg Psvchiatry 1991;54:580-3.
16. Folstein MF. Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognition state of patients for the clinician. J Psychiatry Res 1975; 12:189-98.
17. Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill R, Lessin P, Thai LJ. Clinicalneuropathological correlations in Alzheimer's disease and related dementias. Arch Neural 1994:51:888-95.
18. Hachinski VC, Illif LD, Zilhka E, Duboulay GH, McAllister V Marshall S. Ross Russell RW, Symon L. Cerebral blood flow in dementia. Arch Neural 1975;32:632-7.
19. Hershey LA, Jaffe DF, Greenaugh PG, Yay SC. Validation of cognitive and functional assessment instrument in vascular dementia. Int J Psychiatr Med 1987; 17:183-92.
20. Jacobs JW, Barnhard MK, Delgado A, Strain JJ. Screening for organic mental syndromes in the medically ill. Ann Intern Med 1977;86:46.
21. Jobst KA, Smith AD, Szatman M, Esiri ME, Jaskavilla A, Hindley N, McDonald B, Molyneux AJ. Rapidly progressing atrophy of medial temporal lobe in Alzheimer disease. Lancet 1994:343:829-30.
22. Jobst KA, Smith AD, Szatman M, Molyneux A, Esiri ME, King E, Smith A, Jaskowski A, McDonald B, Wald N. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992;340:1179-83.
23. Kawamura J, Meyer JS, Terayama Y, Weathers S. Cerebral hypoperfusion correlates with mild and parenchymal loss with severe multi-infarct dementia. J Neural Sei 1991; 102:32-8.
24. Kertesz A, Clydesdale S. Neuropsychological deficits in vascular dementia vs Alzheimer's disease. Arch Neuml 1994;51:1226-31.
25. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994;271:985-91.
26. Kühl DE, Melton JE, Riege WH. Patterns of cerebral glucose utilized in depression, multiple infarct dementia, and Alzheimer's disease. In: SokolorTZ, ed. Brain imaging and brain function. New York: Raven Press, 1985:211-26.
27. Lauper LJ, Schelfeus P, Lindeboom J, Barkhof F. Weinstein HC, Jonker C. Medial temporal lobe atrophy in an open population of very old persons. Neurologv 1995:45:747-52.
28. Liu CK, Miller BC, Cummings JL, Melringer CM, Goldberg MA, Honey SL, Benson DL. A quantitative MR1 study of vascular dementia. Neurology 1992;42:138-47.
29. McGeer PL, Kamo H, Harrop R, McGeer EG, Martin WRW, Pate BD, Li DKB. Comparison of PET, MRI and CT with pathology in a proven case of Alzheimer's disease. Neurology 1986;36:1569-74.
30. McKhann G, Drachman DA, Holstein M, Katzman R, Price DD, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-4t4.
31. Meyer JS, Judd BW, Tawaklna T, Rogers RL, Mortel KF. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986;256:2203-9.
32. Meyer JS, Muramatsu K, Mortel KF, Obara F, Shirai T. Prospective CT confirms differences between vascular and Alzheimer's dementia. Stroke 1995;26:735-4t2.
33. Meyer JS, Muramatsu K, Mortel KF, Obara K, Shirai T. Prospective CT confirms differences between vascular and Alzheimer's dementia. Stroke 1995;26:735-442.
34. Meyer JS, Obara K, Muramatsu K, Mortel KF, Shirai T. Cognitive performance after small strokes correlates with ischemia not atrophy of the brain. Dementia 1995; 6:312-22.
35. Meyer JS, Obara K, Takashima S, Muramatsu K, Mortel KF. Problems encountered with longitudinal neurological psychometric and cerebral CT imaging among stroke data bank patients with dementia. Neuroepidemiology 1994; 126:96-102.
36. Meyer JS, Shirai T, Mortel KF, Muramatsu K, Akiyama H. Testing Xe/CT CBF cerebrovascular reserve for identifying migraine and differentiating Alzheimer's from vascular dementia. Acta Neural Scand (in press).
37. Mielke R, Herholz K, Grand M, Kessler J, Heiss WD. Severity of dementia is related to volume of metabolically impaired tissue. Arch Neural 1992;49:909-13.
38. Morris JC, McKeel DW Jr, Fulling K, Torach RM, Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neural 1988;24:17-22.
39. Obara K, Meyer JS, Mortel' KF, Muramatsu K. Cognitive declines correlate with decreased cortical volume and perfusion in dementia of Alzheimer's type. J Neural Sei 1994; 127:96-102.
40. Rapoport SI. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. Cerebrovasc Brain Metab Rev 1991;3:297-335.
41. Reed KM, Rogers RL, Meyer JS. Cerebral magnetic resonance imaging compared in Alzheimer and multiinfarct dementia. JNeuropsychiatry Clin Neurosci 1991;3:51-7.
42. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofinan A, Moody DM, O'Brien MD, Yamaguchi T, Graftnan J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
43. RossorMN. Management of neurological disorders: dementia. J Neural Neurosurg Psychiatry 1994;57:1451-6.
44. Shaw PK, Sullivan EV, Mathalon DH, Lim KO, Davis LF, Yesavage JA, Tinklenberg JR, Pfefferbam A. Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease. Arch Neural 1995;52:392-4t02.
45. Smith GS, de Leon MJ, George AE, Kliyer A, Volkow ND, McRae T, Golomb J, Ferris SH, Reisberg B, Garavino J, La Regina ME. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Arch Neural 1992;49:1142-50.
46. Sultzer DL, Mäher ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C. Cortical abnormalities associated with subcortical lesions in vascular dementia. Arch Neural 1995;52:773-80.
47. Tachibana H, Meyer JS, Okayasu H, Shaw TG, Kaudula P, Rogers RL. Xenon contrast CT-CBF scanning of the brain differentiates normal age-related changes from multi-infarct dementia and senile dementia of the Alzheimer type. J Gerontol 1984;38:415-23.
48. Terayama Y, Meyer JS, Takashima S, Weathers S. Comparison of polio-araiosis and leuko-araiosis in dementias of the ischémie vascular and Alzheimer types. J Stroke Cerebrovasc Dis 1993;3:267-75.
49. Tomlinson BE, Bland G, Roth M. Observations in the brains of demented old people. J Neural Sei 1970; 11:205-42.
50. Wagstaff AJ, McTavish D. Tacrine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drugs Aging 1994;4:510-40.
51. Waldemar G. Functional brain imaging with SPECT in normal aging and dementia. Cerebrovasc Brain Metab Rev 1995;7:89-130.